
Cardiovascular biomarkers
Biomarkers by Therapy Indication
- Autoimmune Disease and Arthritis Biomarkers
- Bone Disease Biomarkers
- Cancer Biomarkers
- Cardiovascular Biomarkers
- Cytokine and Chemokine Biomarkers
- Diabetes and Metabolic Biomarkers
- Endocrine Biomarkers
- Gastrointestinal Biomarkers
- Neuroscience Biomarkers
- Inflammation and Immune Response Biomarkers
- Kidney Function and Toxicity Biomarkers
RBM offers dozens of biomarkers that are correlated to a variety of cardiovascular conditions, including coronary artery disease (CAD), cerebrovascular disease (stroke), cardiomyopathy, congestive heart failure, acute coronary syndrome, and atherosclerosis.
While a diverse set of mechanisms contribute to cardiovascular disease (CVD), inflammatory and metabolic pathways often contribute to hallmark symptoms including hypoxia, artery thickening, blood vessel damage, and the resulting heart muscle damage.
In addition, people with diabetes and certain inflammatory conditions are often found to have cardiovascular risk factors, such as high blood pressure and elevated cholesterol. Our biomarkers reflect various aspects of cardiovascular health, including inflammation, endothelial function, lipid metabolism, and plaque stability. These biomarkers can help evaluate potential therapeutics for a variety of CVD conditions.
Cardiovascular-associated multiplexes
The biomarkers below have demonstrated links to cardiovascular disease in the scientific literature.